heap sjef donor markers for identification of resectable pancreatic cancer patients Arbeidsledig Klassifisere Dare
Advances in the Treatment of Pancreatic Cancer | IntechOpen
Circulating stromal cells in resectable pancreatic cancer correlates to pathological stage and predicts for poor clinical outcomes | npj Precision Oncology
Frontiers | CA19.9 Serum Level Predicts Lymph-Nodes Status in Resectable Pancreatic Ductal Adenocarcinoma: A Retrospective Single-Center Analysis
Selective Labeling and Identification of the Tumor Cell Proteome of Pancreatic Cancer In Vivo | Journal of Proteome Research
Pancreatic Cancer—the Current Landscape - touchONCOLOGY
Clinicodemographic aspect of resectable pancreatic cancer and prognostic factors for resectable cancer | World Journal of Surgical Oncology | Full Text
Frontiers | Predictive Biomarkers for a Personalized Approach in Resectable Pancreatic Cancer
Exploiting the MUC5AC Antigen for Noninvasive Identification of Pancreatic Cancer | Journal of Nuclear Medicine
Definition and Management of Borderline Resectable Pancreatic Cancer
Markers of pancreatic cancer stem cells and their clinical and therapeutic implications | SpringerLink
Cancer of the pancreas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up† - Annals of Oncology
Pancreatic Cancer CT: Prediction of Resectability according to NCCN Criteria | Radiology
Resectable and Borderline Resectable Pancreatic Cancer | SpringerLink
Frontiers | Predictive Biomarkers for a Personalized Approach in Resectable Pancreatic Cancer
Moving the Bar in Pancreatic Cancer
Circulating tumor DNA as a prognostic indicator in resectable pancreatic ductal adenocarcinoma: A systematic review and meta-analysis | Scientific Reports
Pancreatic Cancer CT: Prediction of Resectability according to NCCN Criteria | Radiology
Selective Labeling and Identification of the Tumor Cell Proteome of Pancreatic Cancer In Vivo | Journal of Proteome Research
What Makes a Pancreatic Cancer Resectable? | American Society of Clinical Oncology Educational Book
Circulating stromal cells in resectable pancreatic cancer correlates to pathological stage and predicts for poor clinical outcomes | npj Precision Oncology
Identification of candidate diagnostic and prognostic biomarkers for pancreatic carcinoma - eBioMedicine
Locally Advanced Pancreatic Cancer | MDedge Hematology and Oncology
Identification and prognostic analysis of biomarkers to predict the progression of pancreatic cancer patients | Molecular Medicine | Full Text
Frontiers | CA19.9 Serum Level Predicts Lymph-Nodes Status in Resectable Pancreatic Ductal Adenocarcinoma: A Retrospective Single-Center Analysis
Identification and prognostic analysis of biomarkers to predict the progression of pancreatic cancer patients | Molecular Medicine | Full Text
Treatment for potentially resectable exocrine pancreatic cancer - UpToDate